Cancers, Vol. 13, Pages 317: 18F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib

Conclusion: Tumor response assessment by 18F-FDG-PET outperforms morphological response assessment by CT in patients with advanced radioiodine refractory DTC treated with Lenvatinib, which seems to be correlated with clinical outcomes.

Source: Cancers - January 16, 2021 Category: Cancer & Oncology Authors: Freba Ahmaddy Caroline Burgard Leonie Beyer Viktoria Koehler Peter Bartenstein Matthias P. Fabritius Thomas Geyer Vera Wenter Harun Ilhan Christine Spitzweg Andrei Todica Tags: Article Source Type: research